AIOIX
Price
$9.65
Change
+$0.03 (+0.31%)
Updated
May 8 closing price
Net Assets
452.86M
FSTSX
Price
$18.06
Change
+$0.09 (+0.50%)
Updated
May 8 closing price
Net Assets
3.73B
Ad is loading...

AIOIX vs FSTSX

Header iconAIOIX vs FSTSX Comparison
Open Charts AIOIX vs FSTSXBanner chart's image
American Century International Opps I
Price$9.65
Change+$0.03 (+0.31%)
VolumeN/A
Net Assets452.86M
Fidelity Series International Sm Cap
Price$18.06
Change+$0.09 (+0.50%)
VolumeN/A
Net Assets3.73B
AIOIX vs FSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AIOIX vs. FSTSX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIOIX is a Buy and FSTSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSTSX has more cash in the bank: 3.73B vs. AIOIX (453M). FSTSX pays higher dividends than AIOIX: FSTSX (2.92) vs AIOIX (0.10). AIOIX was incepted earlier than FSTSX: AIOIX (24 years) vs FSTSX (15 years). AIOIX (1.51) is less costly to investors than FSTSX (0.02). AIOIX is a more actively managed with annual turnover of: 135.00 vs. FSTSX (30.00). FSTSX has a lower initial minimum investment than AIOIX: FSTSX (0) vs AIOIX (2500). FSTSX annual gain was more profitable for investors over the last year : 6.95 vs. AIOIX (2.89). FSTSX return over 5 years is better than : 32.55 vs. AIOIX (1.86).
AIOIXFSTSXAIOIX / FSTSX
Total Expense Ratio1.460.027,300%
Annual Report Gross Expense Ratio1.510.027,550%
Fund Existence24 years15 years-
Gain YTD5.02210.92646%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets453M3.73B12%
Annual Yield % from dividends0.102.924%
Returns for 1 year2.896.9542%
Returns for 3 years13.8124.4756%
Returns for 5 years1.8632.556%
Returns for 10 years8.2622.7436%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVPX14.43N/A
N/A
Lord Abbett Fundamental Equity P
FTDZX112.10N/A
N/A
Franklin Biotechnology Discovery Adv
PEIQX38.33N/A
N/A
Principal Equity Income R5
NIEYX16.66N/A
N/A
BNY Mellon International Equity Y
WXCIX12.93N/A
N/A
William Blair Emerg Mkts ex China Gr I